Lee S, Wu X, Son S, Naime D, Reid M, Okubo Y, Sistonen P, Redman C
Lindsley F. Kimball Research Institute, New York Blood Center, New York, USA.
Transfusion. 1996 Jun;36(6):490-4. doi: 10.1046/j.1537-2995.1996.36696269505.x.
The Kell blood group system is complex, consisting of five sets of alleles and expressing high- and low-incidence antigens and at least 11 other independently expressed antigens. The molecular basis of two sets of alleles: KEL1 (K) and KEL2 (k) and KEL6 (Jsa) and KEL7 (Jsb) have been elucidated as single-base mutations leading to amino acid changes. The molecular basis for the KEL3 (Kpa), KEL4 (Kpb), and KEL21 (Kpc) alleles, the KEL11(Cote) and KEL17(Wka) alleles, and for KEL10 (UIa) is now reported.
Genomic DNA from unrelated individuals with KEL:3,-4,-21 [Kp(a+b-c-)], KEL:-3,-4,21 [Kp(a-b-c+)], KEL:17,-11, and KEL:10 (UIa) phenotypes was amplified by polymerase chain reaction (PCR) with primers for the 19 exons of KEL. The PCR products were sequenced and compared to the DNA sequences of a common Kell system phenotype, KEL:-3,4,-21,-17,-10. Base mutations found were confirmed by restriction fragment length polymorphism analysis in which DNA of unrelated persons with similar red cell phenotypes was used.
In all cases, single-base mutations were responsible for the expression of the various antigens. In KEL3 (Kpa), KEL4 (Kpb), and KEL21 (Kpc), point mutations at the same codon in exon 8, encoding amino acid residue 281, distinguish the three genes. KEL4 has the CGG codon for arginine, KEL3 has the TGG codon for tryptophan, and KEL21 has the CAG codon for glutamine. KEL17 has a T1025C mutation in exon 8, encoding a valine-to-alanine amino acid change at residue 302. KEL10 has an A1601T mutation in exon 13, encoding a glutamic acid-to-valine change at residue 494. In all cases, the point mutations created restriction enzyme sites, and PCR-based restriction fragment length polymorphisms confirmed that these point mutations occurred in unrelated persons with the same red cell phenotype.
Single-base substitutions characterize the KEL3, KEL21, KEL17, and KEL10 genes. The allelic relationship of KEL3, KEL4, and KEL21 was confirmed because the mutations occur in the same codon, expressing different amino acids. PCR-based restriction fragment length polymorphisms can be used to distinguish genotypes.
凯尔血型系统很复杂,由五组等位基因组成,表达高频率和低频率抗原以及至少11种其他独立表达的抗原。两组等位基因KEL1(K)和KEL2(k)以及KEL6(Jsa)和KEL7(Jsb)的分子基础已被阐明为导致氨基酸变化的单碱基突变。本文现报道KEL3(Kpa)、KEL4(Kpb)和KEL21(Kpc)等位基因、KEL11(Cote)和KEL17(Wka)等位基因以及KEL10(UIa)的分子基础。
采用聚合酶链反应(PCR),使用针对KEL基因19个外显子的引物,扩增具有KEL:3、-4、-21 [Kp(a+b-c-)]、KEL:-3、-4、21 [Kp(a-b-c+)]、KEL:17、-11和KEL:10(UIa)表型的无关个体的基因组DNA。对PCR产物进行测序,并与常见凯尔血型系统表型KEL:-3、4、-21、-17、-10的DNA序列进行比较。通过限制性片段长度多态性分析确认发现的碱基突变,其中使用具有相似红细胞表型的无关人员的DNA。
在所有病例中,单碱基突变导致了各种抗原的表达。在KEL3(Kpa)、KEL4(Kpb)和KEL21(Kpc)中,编码氨基酸残基281的外显子8中的同一密码子发生点突变,区分了这三个基因。KEL4具有编码精氨酸的CGG密码子,KEL3具有编码色氨酸的TGG密码子,KEL21具有编码谷氨酰胺的CAG密码子。KEL17在外显子8中有一个T1025C突变,导致第302位残基处的缬氨酸到丙氨酸的氨基酸变化。KEL10在外显子13中有一个A1601T突变,导致第494位残基处的谷氨酸到缬氨酸的变化。在所有情况下,点突变产生了限制性酶切位点,基于PCR的限制性片段长度多态性证实这些点突变发生在具有相同红细胞表型的无关人员中。
单碱基取代是KEL3、KEL21、KEL17和KEL10基因特征。KEL3、KEL4和KEL21的等位基因关系得到证实,因为突变发生在同一密码子中,表达不同的氨基酸。基于PCR的限制性片段长度多态性可用于区分基因型。